BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 16757263)

  • 21. Extended criteria donors in liver transplantation: adapting donor quality and recipient.
    Gastaca M
    Transplant Proc; 2009 Apr; 41(3):975-9. PubMed ID: 19376402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ABO blood group-related waiting list disparities in liver transplant candidates: effect of the MELD adoption.
    Barone M; Avolio AW; Di Leo A; Burra P; Francavilla A
    Transplantation; 2008 Mar; 85(6):844-9. PubMed ID: 18360266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donor-recipient MELD-based match in a patient who required three liver grafts in the era of nonstandard donors: case report.
    Avolio AW; Barbarino R; Siciliano M; Annicchiarico BE; Frongillo F; Agnes S; Castagneto M
    Transplant Proc; 2008; 40(6):2067-9. PubMed ID: 18675132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics.
    Weismüller TJ; Negm A; Becker T; Barg-Hock H; Klempnauer J; Manns MP; Strassburg CP
    Transpl Int; 2009 Oct; 22(10):970-8. PubMed ID: 19619170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Donor risk index and organ patient index as predictors of graft survival after liver transplantation.
    Avolio AW; Siciliano M; Barbarino R; Nure E; Annicchiarico BE; Gasbarrini A; Agnes S; Castagneto M
    Transplant Proc; 2008; 40(6):1899-902. PubMed ID: 18675083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure.
    Wang ZX; Yan LN; Wang WT; Xu MQ; Yang JY
    Transplant Proc; 2007 Jun; 39(5):1501-4. PubMed ID: 17580172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of posttransplant Model for End-Stage Liver Disease (MELD) and delta-MELD scores on short-term outcome after living donor liver transplantation.
    Kim JD; Choi JY; Kwon JH; Jang JW; Bae SH; Yoon SK; You YK; Kim DG
    Transplant Proc; 2009 Nov; 41(9):3766-8. PubMed ID: 19917383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of extended donor criteria and changes in the Model for End-Stage Liver Disease score predict patient survival and primary dysfunction in liver transplantation: a retrospective analysis.
    Silberhumer GR; Pokorny H; Hetz H; Herkner H; Rasoul-Rockenschaub S; Soliman T; Wekerle T; Berlakovich GA; Steininger R; Muehlbacher F
    Transplantation; 2007 Mar; 83(5):588-92. PubMed ID: 17353779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver transplant recipient selection: MELD vs. clinical judgment.
    Fink MA; Angus PW; Gow PJ; Berry SR; Wang BZ; Muralidharan V; Christophi C; Jones RM
    Liver Transpl; 2005 Jun; 11(6):621-6. PubMed ID: 15915491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Model for end-stage liver disease: impact of the new deceased donor liver allocation policy in São Paulo, Brazil.
    Monteiro F; Coria SA; Boni R; Pereira LA
    Transplant Proc; 2009; 41(1):226-8. PubMed ID: 19249520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MELD may not be the better system for organ allocation in liver transplantation patients in Singapore.
    Lee YM; Fernandez M; Da Costa M; Lee KH; Sutedja DS; Tai BC; Tan KC; Isaac J; Prabhakaran K; Lim SG
    Singapore Med J; 2006 Jul; 47(7):592-4. PubMed ID: 16810430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function.
    Cywinski JB; Mascha E; Miller C; Eghtesad B; Nakagawa S; Vincent JP; Pesa N; Na J; Fung JJ; Parker BM
    Liver Transpl; 2008 Jan; 14(1):59-65. PubMed ID: 18161840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of a continuous disease severity score to the OPTN liver waiting list.
    Edwards EB; Harper AM
    Clin Transpl; 2001; ():19-24. PubMed ID: 12211782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
    Angermayr B; Luca A; König F; Bertolini G; Ploner M; Gridelli B; Ulbrich G; Reiberger T; Bosch J; Peck-Radosavljevic M
    Eur J Clin Invest; 2009 Jan; 39(1):65-71. PubMed ID: 19087131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
    McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
    Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Split-liver transplantation in the high-MELD adult patient: are we being too cautious?
    Nadalin S; Schaffer R; Fruehauf N
    Transpl Int; 2009 Jul; 22(7):702-6. PubMed ID: 19254241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term postliver transplant survival after the introduction of MELD scores for organ allocation in the United States.
    Yoo HY; Thuluvath PJ
    Liver Int; 2005 Jun; 25(3):536-41. PubMed ID: 15910490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative characteristics and intraoperative transfusion and vasopressor requirements in patients with low vs. high MELD scores.
    Xia VW; Du B; Braunfeld M; Neelakanta G; Hu KQ; Nourmand H; Levin P; Enriquez R; Hiatt JR; Ghobrial RM; Farmer DG; Busuttil RW; Steadman RH
    Liver Transpl; 2006 Apr; 12(4):614-20. PubMed ID: 16555319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver transplantation cost in the model for end-stage liver disease era: looking beyond the transplant admission.
    Buchanan P; Dzebisashvili N; Lentine KL; Axelrod DA; Schnitzler MA; Salvalaggio PR
    Liver Transpl; 2009 Oct; 15(10):1270-7. PubMed ID: 19790155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.